Article

Immunotherapeutic nanoparticles: From autoimmune disease control to the development of…

Biomaterials advances · 2022 · MF. Desimone, A. Dolatshahi-Pirouz, T. Eufrasio-da-Silva, E. Giorgi, A. Khademhosseini, M. De Marzi, YK. Mishra, R. Mitarotonda, G. Orive

Key facts

Title Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines.
First author MF. Desimone, A. Dolatshahi-Pirouz, T. Eufrasio-da-Silva, E. Giorgi, A. Khademhosseini, M. De Marzi, YK. Mishra, R. Mitarotonda, G. Orive
Journal Biomaterials advances
Published Apr 22, 2022
DOI 10.1016/j.bioadv.2022.212726
PubMed ID 35475005
PMC ID PMC9023085
Devices mentioned 212726

At a glance

  • 1–9 FDA submissions mentioned
  • None Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature